By Maitane Sardon Dermapharm on Wednesday confirmed its outlook for the full year after posting a rise in first-half revenue. The German manufacturer of.
By Ben Glickman Shares of Heron Therapeutics rose Monday after the company unveiled a plan to cut $75 million in costs by 2025. The stock was up 6.2% to.
By Chris Wack Verrica Pharmaceuticals shares fell 35% to $4.86 after the company entered into a non-binding term sheet for a term loan facility of up to $125.
By Denny Jacob Verrica Pharmaceuticals on Friday said the Food and Drug Administration approved Ycanth topical solution to treat molluscum contagiosum in.
By Denny Jacob Shares of Verrica Pharmaceuticals were down on Friday after the company said the Food and Drug Administration approved Ycanth topical solution.